S 2569 United States Senate · 118th Congress

Fentanyl Safe Testing and Overdose Prevention Act

This bill clarifies that equipment used to test for fentanyl or xylazine in substances is not subject to restrictions under the Controlled Substances Act. It directly affects people who use drugs and harm reduction organizations providing testing supplies. The key provision amends Section 422 of the Act to explicitly state that testing equipment for these substances is exempt from legal restrictions on possession, sale, or transportation. This allows safer access to testing tools without legal penalties. The bill does not create new programs or funding, only adjusting existing legal language.
Bill status in committee 1 of 4 stages cleared
Introduction
Jul 2023
Committee Review
Floor Vote
President
Introduced Jul 27, 2023 Last action Jul 27, 2023
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Jul 27, 2023
Committee
Read twice and referred to the Committee on the Judiciary.
upper
Jul 27, 2023
Introduced
Introduced in Senate
upper
1 primary · 11 co-sponsors

Sponsors